The purpose of the study COVID-EP is to classify all the complications occurring after the diagnosis of pulmonary embolism in patients tested initially COVID-19 positive and negative by RT-PCR (on nasopharyngeal sample) during the peak of the pandemic in France (April 2020). The patients will be followed for 1 year in order to provide clinical and paraclinical data not yet published in the literature. In order to secondarily confirm the COVID-19 status of initially negative COVID-19 patients (by RT-PCR), a serology test will be performed. The collected complications will then be compared between each of the 3 following groups: [PCR-COVID 19-Neg & Sero-COVID 19-Neg] versus [PCR-COVID 19-Neg & Sero-COVID 19-Pos] versus [PCR-COVID 19-Pos].
Diagnostic Test: Serology test for COVID-19
In order to secondarily confirm the COVID-19 status of initially negative COVID-19 patients (by RT-PCR), a serology test will be performed in two parts:
ELISA test
Rapid Diagnostic tests (only if ELISA test is positive)
Inclusion Criteria:
- Aged ≥ 18 years,
- Diagnosed for pulmonary embolism between April 1st and April 30th, 2020; (treated by
ambulatory care or hospitalized),
- Having given free and informed written consent,
- Being affiliated with or benefiting from a social security scheme.
Exclusion Criteria:
- Subject to a measure for the protection of justice.
Hôpital Saint Joseph Marseille
Marseille, France
Investigator: Roger Rosario, Dr
Cécile Bielmann
0033 (0)4 88 73 10 70
cbielmann@hopital-saint-joseph.fr
Rahmia AHAMADA
0033 (0)4 91 80 71 12
rahamada@hopital-saint-joseph.fr